SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-054880
Filing Date
2024-04-30
Accepted
2024-04-30 15:07:34
Documents
5
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2413095d1_6k.htm 6-K 10451
2 EXHIBIT 99.1 tm2413095d1_ex99-1.htm EX-99.1 15038
3 EXHIBIT 99.2 tm2413095d1_ex99-2.htm EX-99.2 16421
4 EXHIBIT 99.3 tm2413095d1_ex99-3.htm EX-99.3 110482
5 GRAPHIC tm2413095d1_ex99-1img001.jpg GRAPHIC 7164
  Complete submission text file 0001104659-24-054880.txt   163467
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-39458 | Film No.: 24896585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)